World Health Organisation. Health topics: Vaccines 2019. https://www.who.int/topics/vaccines/en/. Accessed 9 Nov 2019.
Andre FE, Booy R, Bock HL, Clemens J, Datta SK, John TJ, et al. Vaccination greatly reduces disease, disability, death and inequity worldwide. Bull World Health Organ. 2008;86:140–6.
Newell DG, Koopmans M, Verhoef L, Duizer E, Aidara-Kane A, Sprong H, et al. Food-borne diseases—the challenges of 20 years ago still persist while new ones continue to emerge. Int J Food Microbiol. 2010;139(Suppl 1):S3–15.
Lekshmi M, Ammini P, Kumar S, Varela MF. The food production environment and the development of antimicrobial resistance in human pathogens of animal origin. Microorganisms. 2017;5:11.
Taylor LE, Swerdfeger AL, Eslick GD. Vaccines are not associated with autism: an evidence-based meta-analysis of case-control and cohort studies. Vaccine. 2014;32:3623–9.
Foundation Merieux. Event: Communication of vaccine benefits beyond the infection prevented. Les Pensieres Center for Global Health, Veyrier du Lac, France. 4-6 December 2017 2017 Available from: https://www.fondation-merieux.org/en/events/communication-of-vaccine-benefits-beyond-the-infection-prevented/. Accessed 1 Apr 2020.
Tin Htar TM, van Den Biggelaar AHJ, Sings H, Ferreira G, Moffatt M, Hall-Murray C, et al. The impact of routine childhood immunization with higher-valent pneumococcal conjugate vaccines on antimicrobial-resistant pneumococcal diseases and carriage: a systematic literature review. Expert Rev Vacc. 2019;18:1069–89.
Weil-Olivier C, van der Linden M, de Schutter I, Dagan R, Mantovani L. Prevention of pneumococcal diseases in the post-seven valent vaccine era: a European perspective. BMC Infect Dis. 2012;12:207.
Griffin MR, Zhu Y, Moore MR, Whitney CG, Grijalva CGUS. hospitalizations for pneumonia after a decade of pneumococcal vaccination. N Engl J Med. 2013;369:155–63.
Dagan R. Impact of pneumococcal conjugate vaccine on infections caused by antibiotic-resistant Streptococcus pneumoniae. Clin Microbiol Infect. 2009;15(Suppl 3):16–20.
Clift C, Salisbury DM. Enhancing the role of vaccines in combatting antimicrobial resistance. Vaccine. 2017;35:6591–3.
Ginsburg AS, Klugman KP. Vaccination to reduce antimicrobial resistance. Lancet Glob Health. 2017;5:e1176–7.
Jansen KU, Anderson AS. The role of vaccines in fighting antimicrobial resistance (AMR). Hum Vaccin Immunother. 2018;14:2142–9.
Fleming-Dutra KE, Hersh AL, Shapiro DJ, Bartoces M, Enns EA, File TM Jr, et al. Prevalence of Inappropriate Antibiotic Prescriptions Among US Ambulatory Care Visits, 2010-2011. J Am Med Assoc. 2016;315:1864–73.
Esposito S, Principi N. Influenza vaccination and prevention of antimicrobial resistance. Expert Rev Vaccines. 2018;17:881–8.
Nichol KL, Nordin JD, Nelson DB, Mullooly JP, Hak E. Effectiveness of influenza vaccine in the community-dwelling elderly. N Engl J Med. 2007;357:1373–81.
Warren-Gash C, Blackburn R, Whitaker H, McMenamin J, Hayward AC. Laboratory-confirmed respiratory infections as triggers for acute myocardial infarction and stroke: a self-controlled case series analysis of national linked datasets from Scotland. Eur Respir J. 2018;51:1701794.
Wong CM, Chan KP, Hedley AJ, Peiris JS. Influenza-associated mortality in Hong Kong. Clin Infect Dis. 2004;39:1611–7.
Chang MS, Nguyen MH. Epidemiology of hepatitis B and the role of vaccination. Best Pract Res Clin Gastroenterol. 2017;31:239–47.
Bresse X, Adam M, Largeron N, Roze S, Marty R. A comparative analysis of the epidemiological impact and disease cost-savings of HPV vaccines in France. Hum Vaccin Immunother. 2013;9:823–33.
Lee SM, Park JS, Norwitz ER, Koo JN, Oh IH, Park JW, et al. Risk of vertical transmission of human papillomavirus throughout pregnancy: a prospective study. PLoS ONE. 2013;8:e66368-e.
Kyaw MH, Lynfield R, Schaffner W, Craig AS, Hadler J, Reingold A, et al. Effect of introduction of the pneumococcal conjugate vaccine on drug-resistant Streptococcus pneumoniae. N Engl J Med. 2006;354:1455–63.
Lee GC, Reveles KR, Attridge RT, Lawson KA, Mansi IA, Lewis JS 2nd, et al. Outpatient antibiotic prescribing in the United States: 2000 to 2010. BMC Med. 2014;12:96.
Andreano E, D’Oro U, Rappuoli R, Finco O. Vaccine Evolution and Its Application to Fight Modern Threats. Front Immunol. 2019;10:1722.
Lau WC, Murray M, El-Turki A, Saxena S, Ladhani S, Long P, et al. Impact of pneumococcal conjugate vaccines on childhood otitis media in the United Kingdom. Vaccine. 2015;33:5072–9.
Levy C, Biscardi S, Dommergues MA, Dubos F, Hees L, Levieux K, et al. Impact of PCV13 on community-acquired pneumonia by C-reactive protein and procalcitonin levels in children. Vaccine. 2017;35:5058–64.
Greenhow TL, Hung YY, Herz A. Bacteremia in Children 3 to 36 Months Old After Introduction of Conjugated Pneumococcal Vaccines. Pediatrics. 2017;139.
Gaglia MM, Munger K. More than just oncogenes: mechanisms of tumorigenesis by human viruses. Curr Opin Virol. 2018;32:48–59.
Krump NA, You J. Molecular mechanisms of viral oncogenesis in humans. Nat Rev Microbiol. 2018;16:684–98.
Dabbagh A, Laws RL, Steulet C, Dumolard L, Mulders MN, Kretsinger K, et al. Progress toward regional measles elimination—Worldwide, 2000-2017. Morb Mortal Wkly Rep. 2018;67:1323–9.
de Vries RD, McQuaid S, van Amerongen G, Yuksel S, Verburgh RJ, Osterhaus AD, et al. Measles immune suppression: lessons from the macaque model. PLoS Pathog. 2012;8:e1002885.
Laksono BM, de Vries RD, McQuaid S, Duprex WP, de Swart RL. Measles virus host invasion and pathogenesis. Viruses. 2016;8:210.
de Swart RL, Ludlow M, de Witte L, Yanagi Y, van Amerongen G, McQuaid S, et al. Predominant infection of CD150 + lymphocytes and dendritic cells during measles virus infection of macaques. PLoS Pathog. 2007;3:e178.
Mina MJ, Kula T, Leng Y, Li M, de Vries RD, Knip M, et al. Measles virus infection diminishes preexisting antibodies that offer protection from other pathogens. Science. 2019;366:599–606.
Gadroen K, Dodd CN, Masclee GMC, de Ridder MAJ, Weibel D, Mina MJ, et al. Impact and longevity of measles-associated immune suppression: a matched cohort study using data from the THIN general practice database in the UK. BMJ Open. 2018;8:e021465.
Mina MJ, Metcalf CJ, de Swart RL, Osterhaus AD, Grenfell BT. Long-term measles-induced immunomodulation increases overall childhood infectious disease mortality. Science. 2015;348:694–9.
Belamarich PR. Measles and malnutrition. Pediatr Rev. 1998;19:70–1.
Carney JM, Warner MS, Borut T, Byrne W, Ament M, Cherry JD, et al. Cell-mediated immune defects and infection. A study of malnourished hospitalized children. Am J Dis Child. 1980;134:824–7.
Ministère du Plan et Suivi de la Mise en œuvre de la Révolution de la Modernité (MPSMRM), Ministère de la Santé Publique (MSP), ICF International. Demographic and Health Survey in the Democratic Republic of Congo 2013-2014: Executive Summary Report. [Enquête Démographique et de Santé en République Démocratique du Congo 2013-2014: Rapport de synthèse.]. Rockville, Maryland, USA: MPSMRM, MSP et ICF International.; 2014.
Ashbaugh HR, Cherry JD, Hoff NA, Doshi RH, Alfonso VH, Gadoth A, et al. Association of previous measles infection with markers of acute infectious disease among 9- to 59-month-old children in the Democratic Republic of the Congo. J Pediatric Infect Dis Soc. 2019;8:531–8.
Ashbaugh H, Cherry JD, Gerber S, Higgins SG, Gadoth A, Alfonso VH, et al. Reported history of measles and long-term Impact on antibody to tetanus in children 6–59 months of age receiving DTP in the Democratic Republic of Congo. Open Forum Infect Dis. 2017;4:S323-S.
UNICEF. Joint statement: Libya launches a national vaccination campaign against measles, rubella and polio 2018. https://www.unicef.org/mena/press-releases/joint-statement-libya-launches-national-vaccination-campaign-against-measles-rubella. . Accessed 2 Apr 2020.
Supporting Active Ageing Through Immunisation (SAATI) Partnership. Adult vaccination—a key component of healthy ageing 2013. https://ilcuk.org.uk/wp-content/uploads/2018/11/Adult-vaccination_a-key-component-of-health-ageing.pdf. Accessed 2 Apr 2020.
Philip RK, Attwell K, Breuer T, Di Pasquale A, Lopalco PL. Life-course immunization as a gateway to health. Expert Rev Vaccines. 2018;17:851–64.
Doherty TM, Connolly MP, Del Giudice G, Flamaing J, Goronzy JJ, Grubeck-Loebenstein B, et al. Vaccination programs for older adults in an era of demographic change. Eur Geriatr Med. 2018;9:289–300.
McElhaney JE, Gavazzi G, Flamaing J, Petermans J. The role of vaccination in successful independent ageing. Eur Geriatr Med. 2016;7:171–5.
Wong CM, Yang L, Chan E, Chan KH, Hedley AJ, Peiris JS. Influenza-associated hospitalisation. Hong Kong Med J. 2009;15(Suppl 9):35–7.
Haq K, McElhaney JE. Immunosenescence: influenza vaccination and the elderly. Curr Opin Immunol. 2014;29:38–42.
Schmader KE, Johnson GR, Saddier P, Ciarleglio M, Wang WW, Zhang JH, et al. Effect of a zoster vaccine on herpes zoster-related interference with functional status and health-related quality-of-life measures in older adults. J Am Geriatr Soc. 2010;58:1634–41.
Andrew MK, Bowles SK, Pawelec G, Haynes L, Kuchel GA, McNeil SA, et al. Influenza vaccination in older adults: recent innovations and practical applications. Drugs Aging. 2019;36:29–37.
Whitney CG, Zhou F, Singleton J, Schuchat A. Benefits from immunization during the vaccines for children program era—United States, 1994-2013. Morb Mortal Wkly Rep. 2014;63:352–5.
Heikkinen T, Tsolia M, Finn A. Vaccination of healthy children against seasonal influenza: a European perspective. Pediatr Infect Dis J. 2013;32:881–8.
Preaud E, Durand L, Macabeo B, Farkas N, Sloesen B, Palache A, et al. Annual public health and economic benefits of seasonal influenza vaccination: a European estimate. BMC Public Health. 2014;14:813.
Attwell K, Dube E, Gagneur A, Omer SB, Suggs LS, Thomson A. Vaccine acceptance: science, policy, and practice in a ‘post-fact’ world. Vaccine. 2019;37:677–82.
Bahri P, Castillon Melero M. Listen to the public and fulfil their information interests—translating vaccine communication research findings into guidance for regulators. Br J Clin Pharmacol. 2018;84:1696–705.
Bahri P, Rago L. CIOMS guide to vaccine safety communication—executive summary. Vaccine. 2019;37:401–8.
Torcel-Pagnon L, Bauchau V, Mahy P, Tin Htar HM, van der Sande M, Mahe C, et al. Guidance for the governance of public-private collaborations in vaccine post-marketing settings in Europe. Vaccine. 2019;37:3278–89.
Signorelli C, Odone A, Conversano M, Bonanni P. Deaths after Fluad flu vaccine and the epidemic of panic in Italy. BMJ. 2015;350:h116.
European Medicines Agency. No evidence that Fluad vaccine caused deaths in Italy 2014. https://www.ema.europa.eu/documents/press-release/no-evidence-fluad-vaccine-caused-deaths-italy_en.pdf. Accessed 2 Feb 2020.
Levi M, Sinisgalli E, Lorini C, Santomauro F, Chellini M, Bonanni P. The, “Fluad Case” in Italy: could it have been dealt differently? Hum Vacc Immunother. 2016;13:379–84.
Ministero della Salute. Influenza: vaccination coverage [Dati coperture vaccinali] 2019. http://www.salute.gov.it/portale/influenza/dettaglioContenutiInfluenza.jsp?lingua=italiano&id=679&area=influenza&menu=vuoto. Accessed 2 Feb 2020.
Black S, Eskola J, Siegrist CA, Halsey N, MacDonald N, Law B, et al. Importance of background rates of disease in assessment of vaccine safety during mass immunisation with pandemic H1N1 influenza vaccines. Lancet. 2009;374:2115–22.
Odone A, Chiesa V, Ciorba V, Cella P, Pasquarella C, Signorelli C. Influenza and immunization: a quantitative study of media coverage in the season of the <<Fluad case>>. Epidemiol Prev. 2015;39:139–45.
HealthMap 2020. http://www.HealthMap.org/. Accessed 2 Apr 2020.
Brownstein JS, Freifeld CC, Reis BY, Mandl KD. Surveillance Sans Frontieres: internet-based emerging infectious disease intelligence and the HealthMap project. PLoS Med. 2008;5:e151.
Break Dengue 2018. https://www.BreakDengue.org/. Accessed 2 Apr 2020.
Lu FS, Hattab MW, Clemente CL, Biggerstaff M, Santillana M. Improved state-level influenza nowcasting in the United States leveraging Internet-based data and network approaches. Nat Commun. 2019;10:147.
Santillana M, Nguyen AT, Dredze M, Paul MJ, Nsoesie EO, Brownstein JS. Combining Search, Social Media, and Traditional Data Sources to Improve Influenza Surveillance. PLoS Comput Biol. 2015;11:e1004513.
Yang S, Kou SC, Lu F, Brownstein JS, Brooke N, Santillana M. Advances in using Internet searches to track dengue. PLoS Comput Biol. 2017;13:e1005607.
Epidemic Prediction Initiative (EPI) 2016. https://predict.cdc.gov/. Accessed 2 Apr 2020.
ADVANCE-Accelerated development of vaccine benefit-risk collaboration in Europe 2016. http://www.advance-vaccines.eu/. Accessed 2 Apr 2020.
VAC4EU: VAccine monitoring Collaboration for Europe 2019. https://vac4eu.org/. Accessed 2 Apr 2020.
DRIVE–Development of Robust and Innovative Vaccine Effectiveness 2020. https://www.drive-eu.org/. Accessed 2 Apr 2020.
Centers for Disease Control and Prevention. Vaccines and immunizations 2020. https://www.cdc.gov/vaccines/index.html. Accessed 2 Apr 2020.
Matheson EC, Derouin A, Gagliano M, Thompson JA, Blood-Siegfried J. Increasing HPV vaccination series completion rates via text message reminders. J Pediatr Health Care. 2014;28:e35–9.
Rand CM, Vincelli P, Goldstein NP, Blumkin A, Szilagyi PG. Effects of phone and text message reminders on completion of the human papillomavirus vaccine series. J Adolesc Health. 2017;60:113–9.
Carolan K, Verran J, Amos M, Crossley M, Redfern J, Whitton N, et al. SimFection: a digital resource for vaccination education. J Biol Educ. 2019;53:225–34.